FT Options LLC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 178 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
FT Options LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2017$1,676,000
+981.3%
111,064
-2.2%
2.52%
+1326.6%
Q4 2016$155,000
-95.6%
113,600
+24.3%
0.18%
-93.7%
Q3 2016$3,539,000
+4.8%
91,400
+108.3%
2.81%
-3.2%
Q2 2016$3,377,000
-21.8%
43,879
-31.1%
2.90%
-35.9%
Q1 2016$4,320,000
+127.6%
63,714
+36.7%
4.52%
+223.2%
Q4 2015$1,898,00046,6001.40%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
Carmignac Gestion 2,028,192$229,389,0001.76%
Orbimed Advisors 1,037,000$117,285,0001.33%
BB BIOTECH AG 255,719$28,922,0000.95%
ALTRINSIC GLOBAL ADVISORS LLC 193,369$21,870,0000.74%
FALCON POINT CAPITAL, LLC 44,573$5,041,0000.67%
Rhenman & Partners Asset Management AB 30,000$3,393,0000.54%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 11,155$1,262,0000.48%
NATIONAL PLANNING CORP 52,400$5,888,0000.44%
HIGHFIELDS CAPITAL MANAGEMENT LP 364,232$41,195,0000.38%
SPHERA FUNDS MANAGEMENT LTD. 15,000$1,697,0000.33%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders